Meyer Characterizes Current Approaches to Diagnosing, Managing, and Studying Cardiac Angiosarcoma


Dr Meyer discusses the rarity of cardiac angiosarcoma, optimizing detection strategies, surgical interventions, and chemotherapy for this patient population, and why immunotherapy has the potential to transform care for patients.

Welcome to OncLiveOn Air®! I’m your host today, Jason Harris.

OncLiveOn Air® is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital and print formats, OncLive® covers every angle of oncology practice, from new technology to treatment advances to important regulatory decisions.

In today's episode, we had the pleasure of speaking with Christian Frederick Meyer, MD, PhD, MS, lead medical oncologist for adult patients with sarcoma at Johns Hopkins University.

Cardiac angiosarcoma has been in the news ever since the death of acclaimed fashion designer Virgil Abloh in November 2021. Cardiac angiosarcoma is a very rare subset of an already rare disease. Dr Meyer said that out of approximately 700 angiosarcomas diagnosed in the United States annually, roughly 50 of those will be cardiac angiosarcoma.

The disease is difficult to detect in its early stages. Most patients present with advanced metastatic disease and survival is poor. Although most patients receive surgery, there is no standard of care and treatments are borrowed from regimens for other sarcomas.

In our interview, Dr Meyer explained why he sees chemotherapy as a vital part of the treatment regimen for eligible patients and why he believes immunotherapy has the potential to transform care for patients with cardiac angiosarcoma.

Check back on Mondays and Thursdays for exclusive interviews with leading experts in the oncology field. For more updates in oncology, be sure to visit and sign up for our e-newsletters.

OncLive® is also on social media. On Twitter, follow us at @OncLive and @OncLiveSOSS. On Facebook, like us at OncLive and OncLive State of the Science Summit and follow our OncLive page on LinkedIn.

If you liked today’s episode of OncLive On Air®, please consider subscribing to our podcast on Apple Podcasts, Spotify, Google Podcasts, Amazon Music, and many of your other favorite podcast platforms,* so you get a notification every time a new episode is posted. While you are there, please take a moment to rate us!

Thanks again for listening to OncLive On Air®.

*OncLive On Air® is available on: Apple Podcasts, Google Podcasts, Spotify, Amazon Music, Audacy, CastBox, Deezer, iHeart, JioSaavn, Listen Notes, Player FM, Podcast Addict, Podchaser, RadioPublic, and TuneIn.

Related Videos
Benjamin Levy, MD
Eric S. Christenson, MD
Dipti Patel-Donnelly, MD, Johns Hopkins
A panel of 4 experts on MDS
A panel of 4 experts on MDS
A panel of 4 experts on MDS
A panel of 4 experts on MDS
A panel of 4 experts on MDS
Christina L. Roland, MD, MS, FACS
A panel of 4 experts on MDS